Dual-targeted nanoparticulate drug delivery systems for enhancing triple-negative breast cancer treatment
S. Zheng, M. Li, W. Xu, J. Zhang, G. Li, H. Xiao, X. Liu, J. Shi, F. Xia, C. Tian, K.-i. Kamei
This paper develops a dual-targeted nanoparticulate drug delivery system (SJNP) combining SN38 and JQ-1 to enhance triple-negative breast cancer treatment by disrupting DNA repair and mitochondrial function.
bioRxiv · Jan 23, 2024Cancer Biology